A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 4, Issue 4, Pages 298-312
Publisher
EMBO
Online
2012-02-13
DOI
10.1002/emmm.201100211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Distinct HIC1-SIRT1-p53 Loop Deregulation in Lung Squamous Carcinoma and Adenocarcinoma Patients
- (2015) Ruo-Chia Tseng et al. NEOPLASIA
- Aberrant Cytoplasm Localization and Protein Stability of SIRT1 is Regulated by PI3K/IGF-1R Signaling in Human Cancer Cells
- (2012) Vanessa Byles et al. International Journal of Biological Sciences
- Sirtuin 1 in malignant transformation: Friend or foe?
- (2011) Yujiang Fang et al. CANCER LETTERS
- The Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin
- (2011) D. A. Velasquez et al. DIABETES
- Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock
- (2011) L. DiTacchio et al. SCIENCE
- Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells
- (2010) Brittney Jung-Hynes et al. CELL CYCLE
- SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
- (2010) Barrie Peck et al. MOLECULAR CANCER THERAPEUTICS
- SIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53
- (2010) Cian J. Lynch et al. PLoS One
- The p53 orchestra: Mdm2 and Mdmx set the tone
- (2010) Mark Wade et al. TRENDS IN CELL BIOLOGY
- p53 and MDM2: Antagonists or Partners in Crime?
- (2009) Christine M. Eischen et al. CANCER CELL
- Signaling to p53: Ribosomal Proteins Find Their Way
- (2009) Yanping Zhang et al. CANCER CELL
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- Sirtuin inhibitors
- (2009) Francisco J Alcaín et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
- (2009) Katsuhiko Nosho et al. MODERN PATHOLOGY
- Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
- (2009) Hyenjong Hong et al. NATURE
- JNK1 Phosphorylates SIRT1 and Promotes Its Enzymatic Activity
- (2009) Nargis Nasrin et al. PLoS One
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- (2008) Sonia Lain et al. CANCER CELL
- Acetylation Is Indispensable for p53 Activation
- (2008) Yi Tang et al. CELL
- SIRT1 Regulates Apoptosis and Nanog Expression in Mouse Embryonic Stem Cells by Controlling p53 Subcellular Localization
- (2008) Myung-Kwan Han et al. Cell Stem Cell
- HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors
- (2008) Capucine Fleuriel et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Sirtuins — novel therapeutic targets to treat age-associated diseases
- (2008) Siva Lavu et al. NATURE REVIEWS DRUG DISCOVERY
- Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
- (2008) E Lara et al. ONCOGENE
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started